Statins Flashcards
High intensity statins
High intensity statins
Atorvastatin 20-80mg (43%-55%) Max dose 10mg when given with ciclosporin Rosuvastatin 10mg-40mg (43%-53%) Simvastatin 80mg (42%)
Total cholesterol, HDL cholesterol and non-HDL cholesterol concentrations should be checked 3 months after starting treatment with a high intensity statin.
NICE recommends to aim for a reduction in non-HDL cholesterol concentration greater than 40%.
Target non-HDL conc. of below 2.5mmol/L
Simvastatin
Dose adjustments
Max. 10mg OD with concurrent use of bezafibrate or ciprofibrate.
Max. 20mg OD with concurrent use of amiodarone, amlodipine, ranolazine.
Max. 20mg OD with concurrent use of CYP3A4 inhibitors: verapamil and diltiazem
Max. 40mg OD with concurrent use of lomitapide or ticagrelor
Max.20mg OD with concurrent use of elbasvir with grazoprevir.
Statins
Mechanism of action
Inhibits HMG-CoA reductase an enzyme involved in making cholesterol. Decrease cholesterol production in the liver and increase clearance of LDL cholesterol from blood to reduce blood LDL levels. Indirectly reduce TG and increase HDL. Through this they slow progression of atherosclerosis and may even reverse it.
Traditionally taken in the evening as there is some evidence that they have a greater effect when dietary intake is at its lowest.
Statins
Adverse effects
Generally safe and well tolerated. Headache and GI disturbances Rare= Muscle pain, myopathy, rhabdomyolysis.=DISCONTINUE and REPORT Rise in liver enzymes (e.g. ALT) Hyperglycaemia
Statins
Contraindications
Caution in patients with high alcohol intake
Pregnancy- discontinue 3 months before attempting to conceive
Caution in those with a history of liver disease
Avoid in active liver disease.
Statin
Monitoring
- non-HDL cholesterol after 3 months
- measure baseline creatinine kinase before initiation. 5 times above UL twice- do not initiate
- liver function- measure serum transaminases (e.g. ALT)3 times above UL
- fasting blood-glucose concentration or HbA1C checked before initiation
ACE inhibitors
Mechanism of action
Blocks ACE to prevent the conversion of angiotensin 1 to angiotensin 2. Angiotensin 2 is a potent vasoconstrictor and stimulates aldosterone secretion. Blocking this conversion reduces afterload because vasodilation the blood vessels reduces blood pressure. Preload (venous return) is also reduced because aldosterone is not secreted to aid sodium and water retention.
ACE inhibitors
Adverse effect
Persistent dry cough
First-dose hypotension. Take at night. Increased risk if taken with diuretic
Hyperkalaemia
Angioedema
ACE inhibitors
Contraindications
Renal artery stenosis
Acute kidney injury
Pregnancy or thinking about conception
Breastfeeding
ACE inhibitors
Interactions
NSAIDs- can precipitate renal failure
Potassium-elevating drugs- potassium supplement, potassium-sparing diuretics
ACE inhibitors
Monitoring
Blood pressure
Renal function
Potassium levels
Relief of symtptoms